PedAM
Pediatric Disease Annotations & Medicines
| Disease | skin disease |
| Phenotype | C0042109|urticaria |
| Sentences | 6 |
| PubMedID- 21841304 | Chronic urticaria is one of the most frequent skin diseases in medical practice. |
| PubMedID- 20687621 | Numerous short- and long-term clinical trials and surveillance studies have shown that twice-daily bepotastine is an effective and generally well tolerated antihistamine in the treatment of patients with allergic rhinitis, chronic urticaria or pruritus associated with skin conditions (eczema/dermatitis, prurigo or pruritus cutaneus). |
| PubMedID- 24105252 | Background and objective: bepotastine is a second-generation histamine h(1) receptor antagonist that is indicated in allergic rhinitis, urticaria, and pruritus associated with skin disease. |
| PubMedID- 24236825 | Background: although urticaria is considered one of the most frequent skin diseases, reliable epidemiologic data are scarce. |
| PubMedID- 24656153 | Background: bepotastine is a second-generation histamine1 receptor antagonist that is used in the treatment of allergic rhinitis, urticaria, and pruritus associated with skin disease. |
| PubMedID- 24191914 | Oral bepotastine is a safe and effective treatment option approved in japan for allergic rhinitis, urticaria and pruritus associated with skin diseases. |
Page: 1